HCM
BHVN icon

Hollencrest Capital Management’s Biohaven BHVN Stock Holding History

Hollencrest Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-840
Closed -$11.5K – 1125
2023
Q1 		$11.5K Hold
840
– – ﹤0.01% 727
2022
Q4 		$11.7K Sell
840
-879
-51% -$12.4K ﹤0.01% 705
2022
Q3 		$254K Buy
+1,719
New +$12.5K 0.03% 213

Other funds holding BHVN

Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Hollencrest Capital Management's BHVN Position: Q2 2023 in Review

Hollencrest Capital Management sold out of Biohaven (BHVN) in Q2 2023, closing a stake of 840 shares — an estimated $11.5K sold.

Hollencrest Capital Management first reported a position in BHVN in Q3 2022 and held it in 3 quarters. The position peaked at $254K in Q3 2022. 188 funds tracked by Wall St. Rank hold BHVN as of Q2 2023.

  • Hollencrest Capital Management reported no remaining Biohaven position as of Q2 2023 after selling out during the quarter.
  • Hollencrest Capital Management sold 840 Biohaven shares in Q2 2023, an estimated $11.5K.
  • Hollencrest Capital Management first reported a position in Biohaven in Q3 2022 and held it in 3 quarters.
  • Hollencrest Capital Management's Biohaven position peaked at $254K in Q3 2022.
  • 188 funds tracked by Wall St. Rank held Biohaven as of Q2 2023.

Based on Hollencrest Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.